Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Neoplasms × Sevoflurane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 11 Colonic Neoplasms 7 Breast Neoplasms 7 Lung Neoplasms 5 Brain Neoplasms 4 Urinary Bladder Neoplasms 3 Carcinoma, Hepatocellular 3 Respiratory Aspiration 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Postoperative Complications 2 Pituitary Neoplasms 2 Ovarian Neoplasms 2 Neoplastic Cells, Circulating 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Quality of Recovery 1 Postoperative Cognitive Complications 1 Pain, Postoperative 1 Neurofibromatoses 1 Neoplasm Metastasis 1 Myofibroma 1 Liver Neoplasms 1 Liver Functions Tests 1 Intraoral Tumor 1 Inflammation 1 Hydrocephalus 1

Interventions

Paclitaxel 35 Carboplatin 28 pembrolizumab 22 Surveys and Questionnaires 20 Letrozole 14 Radiotherapy 13 Bevacizumab 13 Blood Specimen Collection 12 Metformin 11 Megestrol Acetate 11 olaparib 10 dostarlimab 10 Observation 9 Medroxyprogesterone Acetate 9 Indocyanine Green 9 Cisplatin 9 durvalumab 8 lenvatinib 7 Sentinel Lymph Node Biopsy 7 Radiation 7 Magnetic Resonance Spectroscopy 7 Lymph Node Excision 7 Early Intervention, Educational 7 atezolizumab 6 abemaciclib 6 Taxes 6 Specimen Handling 6 Methods 6 Hysterectomy 6 Everolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡